Showing results (451-460 of 19,543) with videos related to

Sort By:
Pageof 1,955
BMC Cancer|June 2, 2016
Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-A multicenter randomized phase III clinical trial (SENORITA trial) protocolJi Yeon Park, Young-Woo Kim, Keun Won Ryu, et al.
BMC Cancer|June 2, 2016
Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancerOskar Eriksson, Åsa Thulin, Anna Asplund, et al.
BMC Cancer|June 2, 2016
Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case-control studyDanny V Colombara, Lisa E Manhart, Joseph J Carter, et al.
BMC Cancer|June 2, 2016
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumoursEva Segelov, Paul Waring, Jayesh Desai, et al.
BMC Cancer|April 10, 2016
Advance care planning--a multi-centre cluster randomised clinical trial: the research protocol of the ACTION studyJudith A C Rietjens, Ida J Korfage, Lesley Dunleavy, et al.
BMC Cancer|May 14, 2016
Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cellsK Vanova, S Boukalova, H Gbelcova, et al.
BMC Cancer|May 23, 2016
Continuous intraoperative monitoring of pelvic autonomic nerves during TME to prevent urogenital and anorectal dysfunction in rectal cancer patients (NEUROS): a randomized controlled trialD W Kauff, K Kronfeld, S Gorbulev, et al.
BMC Cancer|May 25, 2016
Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocolThomas J Vogl, Elsie Oppermann, Jun Qian, et al.
BMC Cancer|May 26, 2016
The effect of soluble E-selectin on tumor progression and metastasisShin-Ae Kang, Celine A Blache, Sandra Bajana, et al.
BMC Cancer|June 5, 2016
HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancerKathy Miller, Javier Cortes, Sara A Hurvitz, et al.
Pageof 1,955